105 related articles for article (PubMed ID: 7525039)
21. Bleeding Control in Advanced Gastric Cancer; Role of Radiotherapy.
Andleeb A; Fatima K; Nasreen S; Sofi MA; Najmi AM; Qadri S; Siraj F
Indian J Palliat Care; 2023; 29(3):279-284. PubMed ID: 37700893
[TBL] [Abstract][Full Text] [Related]
22. Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.
Gajra A; Klepin HD; Feng T; Tew WP; Mohile SG; Owusu C; Gross CP; Lichtman SM; Wildes TM; Chapman AE; Dotan E; Katheria V; Zavala L; Akiba C; Hurria A;
J Geriatr Oncol; 2015 Mar; 6(2):133-40. PubMed ID: 25666905
[TBL] [Abstract][Full Text] [Related]
23. The Dose/Fractionation Debate in Limited-Stage Small Cell Lung Cancer.
Du K; Liao X; Kishi K
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791986
[TBL] [Abstract][Full Text] [Related]
24. Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer.
Lam MB; Li L; Cronin A; Schrag D; Chen AB
Adv Radiat Oncol; 2018; 3(3):382-390. PubMed ID: 30202806
[TBL] [Abstract][Full Text] [Related]
25. Splenic irradiation for splenomegaly: A systematic review.
Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
[TBL] [Abstract][Full Text] [Related]
26. Symptom palliation with QUAD Shot radiation therapy to penile metastasis derived from descending colon cancer: a case report.
Yamamoto A; Ieki H; Shimamura M; Tsujiura M; Yokoe T; Sanuki N; Ojima E; Uchida K; Mohri Y
Int Cancer Conf J; 2023 Jul; 12(3):210-215. PubMed ID: 37251007
[TBL] [Abstract][Full Text] [Related]
27. Thirty-day Mortality in Palliative Radiotherapy: A Retrospective Cohort Analysis in a Single Center.
Katano A; Tongyu G; Minamitani M; Ohira S; Yamashita H
Cancer Diagn Progn; 2023; 3(6):721-725. PubMed ID: 37927804
[TBL] [Abstract][Full Text] [Related]
28. How should we describe the benefits of palliative radiotherapy?
Samant R; Tucker T
Curr Oncol; 2006 Dec; 13(6):230-4. PubMed ID: 22792023
[TBL] [Abstract][Full Text] [Related]
29. Projection of the number of new cases of ovarian cancer in the world.
Gatellier L; Nakata K
Jpn J Clin Oncol; 2024 Feb; 54(2):227-228. PubMed ID: 38243774
[No Abstract] [Full Text] [Related]
30. Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents.
Butala AA; Patel RR; Manjunath S; Latif NA; Haggerty AF; Jones JA; Taunk NK
Adv Radiat Oncol; 2021; 6(1):100624. PubMed ID: 33665491
[TBL] [Abstract][Full Text] [Related]
31. The role of radiotherapy in epithelial ovarian cancer: a literature overview.
Iorio GC; Martini S; Arcadipane F; Ricardi U; Franco P
Med Oncol; 2019 Jun; 36(7):64. PubMed ID: 31165334
[TBL] [Abstract][Full Text] [Related]
32. Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment.
Choi N; Chang JH; Kim S; Kim HJ
Radiat Oncol J; 2017 Jun; 35(2):144-152. PubMed ID: 28712280
[TBL] [Abstract][Full Text] [Related]
33. Fractionated Palliative Pelvic Radiotherapy as an Effective Modality in the Management of Recurrent/Refractory Epithelial Ovarian Cancers: An Institutional Experience.
Bansal A; Rai B; Kumar S; Suri V; Ghoshal S
J Obstet Gynaecol India; 2017 Apr; 67(2):126-132. PubMed ID: 28405120
[TBL] [Abstract][Full Text] [Related]
34. Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells.
Liang B; Kong D; Liu Y; Liang N; He M; Ma S; Liu X
Radiat Oncol; 2012 Dec; 7():213. PubMed ID: 23244773
[TBL] [Abstract][Full Text] [Related]
35. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy.
Yahara K; Ohguri T; Imada H; Yamaguchi S; Kawagoe T; Matsuura Y; Hachisuga T; Korogi Y
J Radiat Res; 2013 Mar; 54(2):322-9. PubMed ID: 23179378
[TBL] [Abstract][Full Text] [Related]
36. Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
Kunos CA; Sill MW; Buekers TE; Walker JL; Schilder JM; Yamada SD; Waggoner SE; Mohiuddin M; Fracasso PM
Gynecol Oncol; 2011 Feb; 120(2):224-8. PubMed ID: 21075438
[TBL] [Abstract][Full Text] [Related]
37. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.
Corn BW; Lanciano RM; Boente M; Hunter WM; Ladazack J; Ozols RF
Cancer; 1994 Dec; 74(11):2979-83. PubMed ID: 7525039
[TBL] [Abstract][Full Text] [Related]
38. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
39. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
40. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.
Tinger A; Waldron T; Peluso N; Katin MJ; Dosoretz DE; Blitzer PH; Rubenstein JH; Garton GR; Nakfoor BA; Patrice SJ; Chuang L; Orr JW
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1256-63. PubMed ID: 11728685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
